| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. My69z: 3 yrs ago -- ICI Agreement with major institution (2052)  (8) |
| 2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1982) |
| 3. My69z: Date: 26-May-2021 Protocol Number: CD15_COVID-19 (1461) (7) |
| 4. Plotinus: You are correct, it is an open label trial. Trial (979) (11) |
| 5. brentie: We're getting some coverage... (978) (24) |
| 6. Riztheinvestor: Exactly what you’ve seen for years before many (891) (10) |
| 7. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (777) |
| 8. ohm20: The question for me is does that last sentence (758) (16) |
| 9. brentie: "“Our understanding of the genetics of cancer, (755) (6) |
| 10. brentie: "Finally, the Leronlimab, Ulocuplumab, (745) (23) |
| 11. KenChowder: You forgot the antecedent: Are you gonna partner (740) (22) |
| 12. My69z: May 8th, 2020: There was also an increases (737) (4) |
| 13. Katangolo: This is extremely intriguing. Thank you. Upon (734) (12) |
| 14. Jake2212: Based on logic and common sense, the stunning (723) (33) |
| 15. Camp2800: When you add up all of the tea leaves you get (722) (10) |
| 16. Figgs: I was trying to put a positive spin on massive (706) (2) |
| 17. Riztheinvestor: We have a AI partner with identity under lock and (699) (2) |
| 18. My69z: Look again @ Leronlimab (PRO 140) Combined With (697) (5) |
| 19. Tprovo: https://www.marketbeat.com/stocks/OTCMKTS/CYDY/sh (681) (10) |
| 20. ohm20: So I turned to our " friend" A I for some (663) (9) |
| 21. Vintool: They have another one lined up..... We are (659) (2) |
| 22. Boatbuilder: This is why I’m hopeful about our pursuing a (659) (14) |
| 23. Colt8806: Maybe it’s time to move on from the DE dream. (658) (2) |
| 24. Riztheinvestor: This my AI. My is really broken tho. Absolutely. (653) (7) |
| 25. thriftycents: 2025 BIO International Convention I don't think (652) (19) |
| 26. mikeyt1818: Sounds like a conversation I had with Crockett (652) (4) |
| 27. dfwl28: https://youtu.be/GIUu239FWMg (641) (8) |
| 28. My69z: Amarex Statistical Analysis Plan for CD07 ( TNBC (637) (3) |
| 29. My69z: On the website, under Cancer @ bottom " There is (637) (3) |
| 30. MGK_2: Here is a refresher on the mechanism of action of (635) (16) |
| 31. Respert24: Your questions simple enough without 5,000 words (627) (27) |
| 32. USS JOHNSTON: Our prior management also 1. kept us solvent and (626) (10) |
| 33. Riztheinvestor: When the FDA completely lost oversight during (626) (7) |
| 34. Vintool: I still feel there will be a connection between (621) (3) |
| 35. mountaineer: Yes the following is AI generated, but sounds (620) (6) |
| 36. Katangolo: Been reflecting on that aswell. Explains the MASH (619) (14) |
| 37. chazzledazzle: I feel you. But I’m strong. And a little needy (619) (6) |
| 38. mfglola: Dr. Weinberg had an oral presentation today at (618) (5) |
| 39. onestepahead: Yes but 99% of available shares to short are (617) (4) |
| 40. MJS719: I believe we are waiting for some new evidence (616) (16) |
| 41. My69z: The PD-1/PD-L1 pathway plays a significant role (616) (8) |
| 42. Riztheinvestor: You have no idea how much that means to me. (613) (6) |
| 43. 2MartiniGi: Inside the Collapse of the F.D.A. How the new (613) (9) |
| 44. brentie: This is from stocktwits. Nothing too exciting (613) (11) |
| 45. My69z: Cytodyn's 12/7/2022 8-k Investor Oncology (608) (9) |
| 46. Riztheinvestor: It’s LIVE. Thank you to those who stood by me. (608) (17) |
| 47. sean007: Small compared to overall float,...Butt,...burn (608) (3) |
| 48. Riztheinvestor: Yeah, NP fumbled…. But the FDA, CRO, and DOJ (605) (12) |
| 49. My69z: SK said in the 2022 video we hired a major (604) (18) |
| 50. Riztheinvestor: Something’s go to give alright. (604) (2) |
